SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001193125-17-373165
Filing Date
2017-12-19
Accepted
2017-12-19 10:51:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6765
  Complete submission text file 0001193125-17-373165.txt   7657
Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3
Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations